SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $1.63M invested in Sonnet BioTherapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$255K
2
+$146K
3
+$101K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$46K
5
Jane Street
Jane Street
New York
+$39K

Top Sellers

1
-$34K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$575K
2
$306K
3
$255K
4
$146K
5
$101K
6
$61K
7
$46K
8
$39K
9
$35K
10
$24K
11
$23K
12
$10K
13
$4K
14
$3K
15
$1K
16
–